Madrigal Pharmaceuticals, Inc.

Newbridge Financial Services Group, Inc. MDGL

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/21/2026

Shares

3,548

Value ($000)

2,066

Weight

0.3%

2025 Q2 - 2025 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/21/2026	2,066	0.3%	3,548	12/31/2025
2025 Q3	11/13/2025	1,670	0.2%	3,642	9/30/2025
2025 Q2	8/19/2025	1,082	0.2%	3,576	6/30/2025